DRTSW
Alpha Tau Medical Ltd.
—
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors. The company has a strategic collaboration agreement to develop and commercialize Alpha DaRT for the treatment of prostate cancer. The company is headquartered in Jerusalem, Israel.
Price History
Fundamentals
| Market Cap | - |
| P/E Ratio (TTM) | - |
| Forward P/E | - |
| EPS (TTM) | - |
| Dividend Yield | - |
| Profit Margin | - |
| Revenue Growth | - |
| ROE | -90.51% |
| Debt/Equity | 20.68 |
| Recommendation | None |
| Analyst Target | - |
| Analysts | - |
| Next Earnings | - |
| Indexes | - |
Technical Indicators
| RSI (14) | - |
| Beta | 1.19 |
| SMA 20 | - |
| SMA 40 | - |
| 52-Week High | $3.59 |
| 52-Week Low | $3.40 |
| 50-Day Avg | - |
| 200-Day Avg | - |
| Avg Volume | - |
| Volume | 8.2K |
Performance Analysis
NEUTRALDRTSW presents a mixed picture with both positive and negative indicators.
Recent News
Last updated: Aug 06, 2026 14:53 UTC
Back to Screener Export Report